Lifecare Neuro Products Ltd receives Neuro-Psychiatric Company of the Year 2021 Award aninews.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aninews.in Daily Mail and Mail on Sunday newspapers.
Shares of Panacea Biotec surged 9 per cent to Rs 411 on the BSE in the intra-day trade on Monday after the company announced that it has received a manufacturing license to produce Sputnik V vaccine at its Baddi (Himachal Pradesh) plant. The stock of one of the leading vaccine and pharmaceutical producers in India had hit a 52-week high of Rs 453.70 on May 28, 2021. The company announces receipt of manufacturing license from Drugs Controller General (India) for Sputnik V vaccine against Covid-19 pursuant to its collaboration with Russian Direct Investment Fund (Russia s sovereign wealth fund). The license is a necessary condition for using Sputnik V produced by Panacea Biotec in India, Panacea Biotec said in a press release on Sunday, July 4, 2021.
Venus Remedies wins legal battle against French firm for paracetamol patent indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.